review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Ming Tan | Q90231711 |
P2093 | author name string | Xi Jiang | |
P2860 | cites work | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q21534928 |
Emerging concepts in the immunopathogenesis of AIDS | Q22241984 | ||
How does HIV cause AIDS? | Q22242244 | ||
The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors | Q24563224 | ||
Alzheimer amyloid hypothesis lives on. | Q51229653 | ||
Enterovirus 71 infection: a new threat to global public health? | Q82263969 | ||
Calicivirus VP2 forms a portal-like assembly following receptor engagement | Q90971077 | ||
Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform | Q91576751 | ||
Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease? | Q92187571 | ||
Heterologous expression of human norovirus GII.4 VP1 leads to assembly of T=4 virus-like particles | Q92405713 | ||
Human VP8* mAbs neutralize rotavirus selectively in human intestinal epithelial cells | Q92560325 | ||
High-resolution cryo-EM structures of outbreak strain human norovirus shells reveal size variations | Q92641753 | ||
Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice | Q92759295 | ||
Rotavirus and severe childhood diarrhea | Q24605360 | ||
Structural basis for the recognition of blood group trisaccharides by norovirus | Q24682901 | ||
World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis | Q26774950 | ||
X-ray crystallographic structure of the Norwalk virus capsid | Q27619935 | ||
Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*) | Q27643845 | ||
Dimerization of Hepatitis E Virus Capsid Protein E2s Domain Is Essential for Virus–Host Interaction | Q27656916 | ||
Crystallography of a Lewis-Binding Norovirus, Elucidation of Strain-Specificity to the Polymorphic Human Histo-Blood Group Antigens | Q27671411 | ||
Crystal Structure of the Avian Astrovirus Capsid Spike | Q27678060 | ||
Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen | Q27678512 | ||
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
Global burden of childhood pneumonia and diarrhoea | Q28288886 | ||
The changing epidemiology of astrovirus-associated gastroenteritis: a review | Q28302569 | ||
Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease | Q30835636 | ||
Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle | Q33341241 | ||
Alzheimer Disease | Q33562441 | ||
Norovirus gastroenteritis, carbohydrate receptors, and animal models | Q33701801 | ||
Subviral particle as vaccine and vaccine platform | Q33812653 | ||
Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs | Q34059409 | ||
Branched-linear and agglomerate protein polymers as vaccine platforms | Q34064413 | ||
Research and development of universal influenza vaccines | Q34093195 | ||
The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors | Q34123964 | ||
Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis | Q34153875 | ||
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis | Q34227701 | ||
Structural requirements for the assembly of Norwalk virus-like particles | Q34335587 | ||
A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease | Q34376103 | ||
The pathogenesis of senile plaques | Q34421483 | ||
Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production | Q34485266 | ||
Controlling influenza virus replication by inhibiting its proton channel | Q34600414 | ||
Norovirus P particle efficiently elicits innate, humoral and cellular immunity | Q34702360 | ||
Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles | Q34724844 | ||
Norovirus-host interaction: multi-selections by human histo-blood group antigens | Q35146233 | ||
Structure determination of feline calicivirus virus-like particles in the context of a pseudo-octahedral arrangement | Q35201812 | ||
A candidate dual vaccine against influenza and noroviruses | Q35301295 | ||
Aetiology-Specific Estimates of the Global and Regional Incidence and Mortality of Diarrhoeal Diseases Commonly Transmitted through Food | Q35859832 | ||
Serological Correlates of Protection against a GII.4 Norovirus | Q35901978 | ||
Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner | Q35943850 | ||
Global Economic Burden of Norovirus Gastroenteritis | Q35999480 | ||
Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens | Q36246385 | ||
Evaluation of anti-norovirus IgY from egg yolk of chickens immunized with norovirus P particles | Q36392947 | ||
Noroviral P particle: structure, function and applications in virus-host interaction | Q36429481 | ||
Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus | Q36445296 | ||
A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus | Q36519453 | ||
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein | Q36685153 | ||
Polyvalent complexes for vaccine development | Q36792270 | ||
Norovirus-host interaction: implications for disease control and prevention | Q36876480 | ||
Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus | Q36914794 | ||
Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B. | Q36970026 | ||
A dual vaccine candidate against norovirus and hepatitis E virus | Q37502688 | ||
A dual chicken IgY against rotavirus and norovirus | Q37716268 | ||
Virus-like particle-based human vaccines: quality assessment based on structural and functional properties | Q38152530 | ||
Histo-blood group antigens: a common niche for norovirus and rotavirus | Q38194256 | ||
Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations | Q38557262 | ||
Norovirus vaccines under development | Q38698429 | ||
VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans. | Q38714968 | ||
Recent advancements in combination subunit vaccine development | Q38819439 | ||
Norovirus P particle: an excellent vaccine platform for antibody production against Alzheimer's disease | Q40562871 | ||
Laboratory efforts to cultivate noroviruses | Q40600126 | ||
Prestress strengthens the shell of Norwalk virus nanoparticles. | Q40762621 | ||
A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice | Q40925262 | ||
Elicitation of HIV-1 neutralizing antibodies by presentation of 4E10 and 10E8 epitopes on Norovirus P particles | Q41235708 | ||
Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children | Q41925938 | ||
Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry | Q46851930 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P577 | publication date | 2019-09-12 | |
P1433 | published in | Pharmaceutics | Q27723332 |
P1476 | title | Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development | |
P478 | volume | 11 |